Letermovir

ATC J05AX18 · 10 markets · 36 records

Letermovir 10 markets · 36 records Forms

US 6 records · 5 strengths

CA 5 records · 3 strengths

AU 5 records · 5 strengths

  • 240 mgtabletPREVYMIS letermovir 240 mg film-coated tablet blister pack also in US·CA·SG +3 unknown
  • 480 mgtabletPREVYMIS letermovir 240 mg film-coated tablet blister pack also in US·CA·SG +2 unknown
  • 480 mginjectionPREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial unknown
  • 240 mginjectionPREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial unknown

Records without a stated strength · 1 PREVYMIS

HK 4 records · 1 strengths

    Records without a stated strength · 1 PREVYMIS、PREVYMIS CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/12ML

    SG 3 records · 3 strengths

    TW 3 records · 3 strengths

    Records without a stated strength · 1 Prevymis Concentrate for Solution for Infusion 20mg/mL、滅巨斯輸注用濃縮溶液20毫克/毫升

    GB 2 records · 2 strengths

    • 240 mgtabletPREVYMIS also in US·CA·AU +3
    • 240 mg/12 mLinjectionPrevymis 240mg/12ml concentrate for solution for infusion vials

    ES 2 records · 2 strengths

    MX 2 records · 2 strengths

      Records without a stated strength · 2 PREVYMIS PREVYMIS

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 PREVYMIS

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.